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ABSTRACT In this paper, a general procedure is described to determine thermodynamic parameters associated with the
interaction of thrombin receptor antagonistic peptides (TRAPs) with immobilized nonpolar ligands. The results show that
these interactions were associated with nonlinear van’t Hoff dependencies over a wide temperature range. Moreover,
changes in relevant thermodynamic parameters, namely the changes in Gibbs free energy of interaction, Gassoc
0 , enthalpy
of interaction, Hassoc
0 , entropy of interaction, Sassoc
0 , and heat capacity, Cp
0, have been related to the structural properties
of these TRAP analogs. The implications of these investigations for the design of thrombin receptor agonists/antagonists with
structures stabilized by intramolecular hydrophobic interactions are discussed.
LIST OF SYMBOLS
b(0), b(1), b(2),
b(3) . . .
Coefficients for the polynomial
dependency of ln k versus 1/T
c1 Mole fraction of displacing solvent
Aapolar Apolar accessible surface area
Apolar Polar accessible surface area
Atotal Total accessible surface area
Cp
0 Change in the heat capacity for the
association of the polypeptide Pi with
the nonpolar ligands
Gassoc
0 Change in Gibbs free energy due to the
association of the polypeptide Pi with
the nonpolar ligands
Hassoc
0 Change in the enthalpy due to the
association of the polypeptide Pi with
the nonpolar ligands
Sassoc
0 Change in the entropy due to the
association of the polypeptide Pi with
the nonpolar ligands
 Volume fraction of organic solvent in
binary water–solvent mixture
 Phase ratio of the chromatographic
system ( VS/VM)
Kassoc Equilibrium binding constant
k Capacity factor, k  (te  t0)/t0 
(nS/nM)  (VS/VM)  Kassoc  
ln k Logarithm of the capacity factor, k
ln k0 Value of ln k when ci 3 0, or  3 0
nS Number of moles of the peptide in the
bound states
nM Number of moles of the peptide in the
free states
Nres Number of amino acid residues in a
polypeptide
r2 Correlation coefficient
R Gas constant
t0 Retention time of noninteracting solute
te Retention time of a polypeptide Pi
T Temperature in degrees Kelvin
TH Temperature at which Hassoc
0 3 0
TS Temperature at which TSassoc
0 3 0
VM Volume of the solvent in the system
VS Volume of the immobilized ligands
plus support matrix in the system
INTRODUCTION
Protease-activated receptors (PARs) play an important role
in platelet function. In particular, various serine proteases,
including thrombin, are known to activate PARs by cleav-
ing their amino-terminal extracellular domains to reveal a
new amino terminus that can then function as a tethered
ligand. By binding intramolecularly to the receptor, the
tethered ligand causes transmembrane signaling (Vu et al.,
1991). In human platelets, a dual receptor system for the
activation of PARs has been found to occur (Kahn et al.,
1998). From an experimental perspective, the existence of
this second receptor-mediated pathway adds a further level
of complexity in the cell biology of PAR activation. How-
ever, it also has the potential to provide exquisite levels of
regulation for a diverse range of physiological functions,
including a safeguard against irreversible activation or in-
hibition of a single class of PAR receptor by potent ago-
nists/antagonists.
The thrombin receptor (PAR-1) is a transmembrane G-
protein-coupled structure that is activated by serine protease
cleavage of its extracellular N-terminus to expose an agonist
peptide ligand that is tethered to the receptor itself. Syn-
thetic peptides that contain the agonist motif of human
PAR-1, such as H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-OH
(TRAP-1) (Mari et al., 1994), are capable of receptor acti-
vation in the absence of thrombin. TRAP-1 has been used as
a pharmacological tool to probe the function of the PAR-1
receptor in various cell types (Mari et al., 1994; Seiler et al.,
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1996). Replacement of Phe2 with Ala in TRAP-1, with
elimination of the -phenyl side chain group, results in
complete receptor inactivation (Nose et al., 1998a). Other
results indicated that the electrostatic interaction of the
guanidino-group of Arg5 is important for TRAP-1 to inter-
act with its receptor (Nose et al., 1998b). On the basis of
introduced conformational perturbations, structure–function
relationships of various bioactive thrombin receptor-activat-
ing peptide analogs (TRAPs), prepared by solid phase pep-
tide synthesis procedures, have been explored in vitro with
cultured human glomerular messiangial cells (Troyer et al.,
1992), naturally thrombin-responsive CCL-29 cells and Jur-
kat T cells (Mari et al., 1994) and in vivo in rabbit models
(M. Cunningham, K. Tipping, S. Holdsworth, R. I. Boysen,
and M. T. W. Hearn, unpublished results). Based on these
latter and other studies (Ceruso et al., 1999), it has been
proposed that an extended structure of the agonist peptide is
responsible for receptor recognition, with a hydrophobic
contact occurring between the side chains of Phe2 and Leu4.
To gain further insight into the conformational and inter-
active behavior of TRAP analogs, the interaction of
TRAP-1 and a complete set of Ala-replacement analogs
(Table 1) with immobilized n-octyl ligands has been inves-
tigated. The use of immobilized n-alkyl or phospholipid
ligands to illuminate the biophysical basis of the structure–
function behavior of bioactive peptides has attracted in-
creasing attention during the past several years (Houston et
al., 1998; Kondejewski et al., 1999; Beyermann et al., 1996;
Hearn, 2001b). In particular, these procedures permit the
thermodynamics of peptide–ligand interaction to be studied.
Insight can thus be gained into the role of intramolecular
hydrophobic stabilization or the consequences of solvation/
desolvation effects, permitting correlations to be established
with membrane-associated receptor binding events and the
respective changes in the Gibbs free energy, Gassoc0 , en-
thalpy, Hassoc0 , entropy, Sassoc0 , and heat capacity, Cp0, for
peptide–ligand interactions determined. In the present stud-
ies, changes in thermodynamic parameters associated with
TRAP-peptide–n-octyl ligand interactions have been eval-
uated in terms of the molecular structure and the associated
linear free energy relationships of these peptides. Based on
these results, guidelines can be proposed to facilitate the
design of TRAP-1 analogs with enhanced stability in non-
polar environments.
EXPERIMENTAL PROCEDURES
Chemicals and reagents
Acetonitrile (HPLC grade) was obtained from Biolab Scientific Pty. Ltd.
(Sydney, Australia); all other solvents were of analytical grade. Water was
distilled and deionized in a Milli-Q system (Millipore, Bedford, MA).
Trifluoroacetic acid (TFA), N,N-dimethylformamide (DMF), piperidine,
1-hydroxybenzotriazole (HOBt), O-benzotriazole-N,N,N,N-tetramethyl-
uronium-hexafluorophosphate (HBTU), Boc-L-Pro-PAM-resin and all of
the L--Boc-protected and L--Fmoc-protected amino acids were obtained
from Auspep Pty. Ltd. (Melbourne, Australia). Thioanisole, acetic anhy-
dride, 1,3-dilsopropylethylamine (DIEA), and trifluoromethanesulphonic
acid (TMFSA) were obtained from Aldrich Chemical Co. (Milwaukee,
WI).
Solid phase peptide synthesis
The thrombin receptor antagonistic peptides, TRAP-1 (H-Ser-Phe-Leu-
Leu-Arg-Asn-Pro-OH), and the alanine-scan analogs, TRAP-2 (H-Ser-
Ala-Leu-Leu-Arg-Asn-Pro-OH), TRAP-3 (H-Ser-Phe-Ala-Leu-Arg-Asn-
Pro-OH), TRAP-4 (H-Ser-Phe-Leu-Ala-Arg-Asn-Pro-OH), TRAP-5
(H-Ser-Phe-Leu-Leu-Ala-Asn-Pro-OH), and TRAP-6 (H-Ser-Phe-Leu-
Leu-Arg-Ala-Pro-OH) respectively, were synthesized by 9-fluorenyl-
methyloxycarbonyl (Fmoc)/Boc solid phase peptide synthesis procedures
(Fields and Noble, 1990; Keah et al., 1998; Boysen and Hearn, 2000). The
synthesis of TRAP was performed using the Boc-L-Pro-PAM-resin (0.88
mmole/g) at a 0.5-mmol scale using a combined Fmoc/Boc strategy.
Typically, the appropriate Boc- or Fmoc-amino acids (3 eq), HOBt (3 eq)
and HBTU (3 eq) dissolved in DMF (5 ml) with 0.25 ml DIEA were used.
During the synthesis, the presence of free amino groups was monitored by
the ninhydrin test (Kaiser et al., 1970). The synthesis was started using
Boc-chemistry (TFA deprotection of Pro) with the following two Boc-
protected amino acids double-coupled. This double-coupling strategy was
predicated on the fact that the extent of deprotection of the first residue, Pro
(being a secondary amino acid), cannot be tested with the ninhydrin
TABLE 1 Peptide code, sequence, molecular weight (MW), accessible surface areas, Atot (Å
2) for the unfolded and folded
forms of the peptide analogs, relative hydrophobicity, and RP-HPLC elution order of the TRAP peptide analogs
Peptide Sequence MW
Atot (Å2)* Relative
Hydrophobicity,
hydr
†
RP-HPLC
Elution
Order‡Unfolded Globular
TRAP-1 Ser-Phe-Leu-Leu-Arg-Asn-Pro 846.0 1015.2 917.0 20.86 4
TRAP-2 Ser-Ala-Leu-Leu-Arg-Asn-Pro 769.9 923.9 855.9 14.24 1
TRAP-3 Ser-Phe-Ala-Leu-Arg-Asn-Pro 803.9 964.7 883.4 16.91 3
TRAP-4 Ser-Phe-Leu-Ala-Arg-Asn-Pro 803.9 964.7 883.4 16.91 2
TRAP-5 Ser-Phe-Leu-Leu-Ala-Asn-Pro 760.9 913.1 848.5 22.22 5
TRAP-6 Ser-Phe-Leu-Leu-Arg-Ala-Pro 803.3 964.0 882.9 24.75 6
*The accessible surface areas Atot (Å2) for unfolded peptides were calculated according to the relationship Atot  1.2 (MW) (Spassov et al., 1997) and
for globular peptides according to the relationship Atot  6.6 (MW)0.732 (Makhatadze and Privalov, 1995), where MW is the molecular weight.
†The relative hydrophobicity of the TRAP peptide analogs in the presence of immobilized n-octyl ligands were calculated according Wilce et al. (1995).
‡The RP-HPLC elution order was determined under isocratic conditions on Zorbax 300SB-C8 columns using water-acetonitrile (86:14 v/v) containing
0.09% (v/v) TFA.
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reagent, whereas the ninhydrin test gives ambiguous results following
deprotection of Asn (and Ser) (Fontenot et al., 1991). After each depro-
tection with TFA, neutralization was performed with 10% (v/v) DIEA in
DMF. Following incorporation of the Asn residue, the synthesis was then
based on Fmoc-chemistry with deprotection of the next and subsequent
residues achieved with 20% (v/v) piperidine in DMF. Earlier utilization of
Fmoc-chemistry in the SPPS inevitably lead to the release of the AsnPro
dipeptide from the resin as the cyclic dipeptide diketopiperazine (Fields
and Noble, 1990; Bornstein and Balian, 1977).
The synthesis of the Ala-scan TRAP analogs was performed using
similar methods, with the exception that a split resin strategy was used,
whereby after each coupling the resin was dried and 1⁄5 of the resin was
placed in a separate vessel, prior to coupling the Boc- or Fmoc-Ala residue.
The syntheses then proceeded in parallel in an analogous manner to that
used for the parent peptide, with the respective peptide-resin repeatedly
dried and subdivided until all peptide sequences had been synthesized.
The cleavage of the crude peptide products was performed with TFMSA
by incubating 500 mg peptide-resin with 0.25 ml ethane-1,2-dithiol and 0.5
ml thioanisole for 10 min on ice. TFA (5 ml) was added and the mixture
incubated for further 10 min on ice. Finally 0.5 ml TFMSA (0.5 ml) was
added dropwise and the resulting solution stirred at room temperature for
2 h. After completion of the TFMSA cleavage of the crude peptide
products from the resin, the crude peptide was precipitated by the addition
of 40 ml cold diethyl ether, the solution stirred for 1 min and then filtered.
The precipitate was extracted with 25 ml TFA through the glass sintered
filter directly into a round bottom flask. The volume of filtrate was reduced
in vacuo with a rotary evaporator (Buchi, Labortechnik AG, Flawil, Swit-
zerland) and again precipitated by adding ice-cold diethylether. The pre-
cipitate, containing the crude peptide, was recovered by filtration and the
ether disregarded. The precipitate was dissolved in 50% (v/v) acetonitrile/
water, lyophilized and the crude peptide stored at 353 K (20°C).
Peptide purification
The six crude synthetic peptides were each purified by gradient elution
reversed-phase high-performance liquid chromatography (RP-HPLC) us-
ing a Waters 600/486 HPLC system with a TSK-ODS-120 T column
(300  21.5 mm inside diameter, Tosoh Corp. Yamaguchi, Japan) packed
with 10 m, 300 Å pore-sized octadecyl silica. The eluents used were: A,
0.1% TFA in water, and B, 0.09% TFA in 60% (v/v) acetonitrile-water,
with a linear gradient of 25–75% B over 90 min. Ultraviolet (UV) detection
was used at 254 nm except for TRAP-2 (in which Ala replaces Phe2) where
detection at 214 nm was used. The flow rate was 7.5 ml/min. Because
TRAP-1 precipitates in eluent A at high concentrations, this peptide was
dissolved in 0.09% TFA, 25% acetonitrile (v/v) in water, and 50–150 mg
aliquots were injected. Recovered fractions were analyzed using the Waters
600/486 HPLC system by analytical RP-HPLC and a TSK-ODS-120 T
column (150  4.6 mm inside diameter, Tosoh Corp.), packed with 5 m,
300 Å average pore size octadecyl silica. The eluents used were the same
as above for the semi-preparative separation, with a linear gradient of
0–100% B over 60 min, UV detection at 214 nm, and a flowrate of 1
ml/min. The molecular masses of the purified peptides were confirmed by
electrospray ionization mass spectrometry (ESI-MS) using a Micromass
platform (II) quadrupole MS with an electrospray source with Masslynx
NT Ver. 3.2 software (Micromass, Cheshire, UK). The synthetic peptides
in 50:50 (v/v) ACN/water, with 3% (v/v) formic acid were infused into the
instrument at a speed of 10 l per minute. The ESI-MS spectra of the
TRAP peptides were acquired at 343 K at 55V/50V over the mass/charge
(m/z) range of 200–2000.
Molecular modeling
Molecular modeling and energy minimization were performed using the
CS Chem3D Pro 4.0 software (CambridgeSoft, Corp., Cambridge, MA).
Standard molecular dynamics was performed in 10,000 steps by heating the
molecule to 600 K at a rate of 1.000 kcal/atom/ps. Energy-minimized
structures of each peptide were acquired using the molecular mechanics
subroutine MM2 (Allinger, 1977; Allinger et al., 1988; Torrens, 2000) with
2-fs intervals, with average backbone and side-chain conformations deter-
mined from the overlap of five acquired structures. The molecular surface
area, Amol, solvent accessible surface area, Asolv, and hydrophobic
surface area, Ahydr, of the TRAP peptides (Table 1) in their folded
(globular) conformations, and the corresponding surface areas for the
TRAP-related peptides in their unfolded conformations, were calculate
according to established procedures (Makhatadze and Privalov, 1995;
Spassov et al., 1997). The relative hydrophobicities of the TRAP peptide
analogs in the presence of immobilized n-octyl ligands were calculated
according well documented approaches (Wilce et al., 1995).
Instrumental methods
Analytical chromatographic measurements were performed on a Hewlett
Packard HP1090 chromatograph and a HP Chemstation (Hewlett Packard,
Waldbronn, Germany). All peak profiles were monitored at 215 nm.
Temperature was controlled by immersing the analytical columns in a
thermostated column coolant-jacket (Alltech Associates, Deerfield, IL)
coupled to a recirculating cooler (Colora Messtechnik GmbH, Lorchwutt,
Germany). All chromatographic experiments were performed on 150 4.6
mm inside diameter Zorbax 300SB-C8 columns (Rockland Technologies,
Inc., Littlefalls, DE).
Determination of capacity factor, k,
dependencies
Bulk solvents were filtered and degassed by sparging with helium. Capac-
ity factor measurements (Purcell et al., 1999) were performed using water
containing 0.09% (v/v) TFA with acetonitrile contents of 14, 15, 16, 17, 18,
19, and 20%, respectively with Zorbax 300SB-C8 columns operated at a
flow rate of 1 ml/min and at temperatures of 278–338 K in 5-K increments.
Solutions of TRAP-1, -2, -3, -4, -5, and -6 peptides were prepared by
dissolving the peptide at a concentration of 1 mg/ml in 0.09% (v/v) TFA
in water. The injection size varied between 2.5 and 3.5 g. Under these
concentration and mass loading conditions, the TRAP-1 to TRAP-6 pep-
tides exist as monomeric species. All data points were derived from at least
duplicate measurements with retention times between replicates varying
typically by less than 1%. The column dead volume was measured as the
retention time of the noninteractive solute, sodium nitrate. Various ther-
modynamic and extra-thermodynamic parameters were calculated using
the Eudoxos and Hephaestus software developed in this laboratory, cou-
pled to the Excel version 5.0 program (Microsoft), whereas the statistical
analysis involved the Sigmaplot 4.01 program (Jandel Scientific) linear and
nonlinear regression analysis. The relative standard deviations of the rep-
licates for the k measurements were 	0.6%, i.e., the standard deviation
of the k values were smaller than the size of the data points shown in Figs.
1, 2, 4, and 5, respectively. Similarly, the precision in the temperature
measurements was 	0.5 K over the studied temperature range.
RESULTS AND DISCUSSION
General considerations
The extent of binding of a peptide to an immobilized non-
polar ligand as a function of experimental conditions can be
evaluated for a reversible, equilibrium interaction from the
ratio of the bound-to-free peptide concentration (Hearn,
1998, 2000). When measured with a solid/liquid two-phase
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system, such as occurs in membrane-based environments or
chromatographic adsorption formats, this concentration de-
pendency can be expressed in terms of the unitless term k,
also known as the capacity factor, which is the ratio of the
peptide mass bound to the immobilized ligand(s) to the
peptide mass in free solution. For convenience, k is usually
expressed as a concentration ratio such that
k
nS
nM
	
VS
VM
 Kassoc	
VS
VM
 Kassoc	 , (1)
where nS and nM are the number of moles of the peptide in
the bound and free states respectively, Kassoc is the equilib-
rium binding constant and  the phase ratio of the system,
defined as the ratio VS/VM, where VS and VM are, respec-
tively, the volume of the immobilized ligands/support ma-
trix and the volume of the solvent in the system. Similarly,
the dependency of k on temperature can be evaluated in
terms of the respective enthalpic and entropic thermody-
namic parameters, such that
ln k
Hassoc
0
RT


Sassoc
0
R

 ln , (2)
where Hassoc
0 and Sassoc
0 are the apparent changes in
enthalpy and entropy associated with the interaction, R is
the universal gas constant, and T is the absolute temperature
in degrees Kelvin. The equilibrium binding behavior of a
large number of ligands for G-protein coupled receptors and
ligand-gated ion channel receptors have recently been ana-
lyzed in considerable detail based on these relationships
(Borea et al., 2000), revealing that the discrimination of
various agonists/antagonists mechanistically appears to be a
consequence of the thermodynamic reorganization of sol-
vent molecules that occur during the binding. Analogous
situations occur when peptide agonists/antagonists interact
with immobilized nonpolar n-alkyl or phospholipid li-
gand(s). When this interaction is an isothermic and isobaric
(constant pressure) process, linear van’t Hoff plots are an-
ticipated, with the change in heat capacity, Cp
0, equalling
zero (Boysen et al., 1999; Hearn et al., 1999). However,
when the interaction follows a homothermic or heterother-
mic process, curvilinear van’t Hoff plots are anticipated
whereby Cp
0 
 0 and is a function of T (Boysen et al.,
1999; Hearn et al., 1999). Although fitting of experimental
data to the linear form of the van’t Hoff dependency has
often been used in studies related to the thermal stability of
proteins in bulk solution, differential scanning and isother-
mal titration microcalorimetric studies with proteins bound
to chemical defined surfaces or undergoing ligand-binding
events have shown that the temperature dependence of Cp
0
is often associated with dome-shaped (or inverted dome-
shaped) dependencies of the logarithmic equilibrium asso-
ciation constant, ln Kassoc (or Gassoc
0 ) on temperature
(Klotz, 1999). Similarly, nonlinear van’t Hoff behavior has
been observed for peptides and proteins in both reversed-
phase and hydrophobic interaction chromatographic sys-
tems. Such behavior can be approximated (Melander et al.,
1984; Vailaya and Horvath, 1996; Haidacher et al., 1996;
Hearn, 2001a) as a quadratic relationship linking k and the
temperature, T,
ln k b(0)

b(1)
T


b(2)
T2

 ln . (3)
Hence, from Eqs. 1 and 2, the change in enthalpy, Hassoc
0 ,
can be expressed as
Hassoc
0 Rb(1)
 2b(2)T  , (4)
whereas the change in entropy, Sassoc
0 , is given by
Sassoc
0  Rb(0) b(2)T2  , (5)
and the change in heat capacity, Cp
0, is given by
Cp
0 R2b(2)T2  , (6)
where b(0), b(1), and b(2) are steri-electronic parameters
specific for the structure of the peptide (or protein). In the
present investigation, the interactive behavior of a series of
TRAP-related peptide analogs with immobilized n-octyl
ligands has been evaluated according to Eqs. 1–6 from the
corresponding ln k versus 1/T plots measured under revers-
ible, equilibrium-binding conditions at fixed solvent com-
position(s). This analysis permits the respective thermody-
namic parameters associated with the interaction to be
derived and quantified, and the related extra-thermody-
namic dependencies to be evaluated in terms of correspond-
ing structural relationships.
Figure 1 shows the plot of the logarithmic capacity factor,
ln k, of TRAP-1 versus the volume fraction of acetonitrile,
FIGURE 1 Plots of logarithmic capacity factor, ln k, versus the volume
fraction of organic solvent, , for the TRAP-1 at different temperatures
from 278 to 338 K (5–65°C).
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, for water-acetonitrile mixtures of different acetonitrile
contents over the temperature range 278–338 K. The ex-
perimental data obtained were fitted to first and second
order dependencies of ln k on , with regression coeffi-
cients falling within the range of r2  0.9902–0.9992 for
the first-order fit and r2  0.9983–0.9999 for the second
order fit. The higher correlation coefficients observed when
the TRAP-1 data were fitted to quadratic dependencies of
ln k on  are consistent with the well-known parabolic
binding relationship for polypeptides and proteins on ad-
sorption to immobilized n-alkyl ligands from aquo-organic
solvent mixtures (Hearn et al., 1999, 2001a) Similarly, the
corresponding plots at 298 K for the TRAP 1–6 peptides
where, in all cases, the ln k versus  plots were curvilinear
(Fig. 2).
For the TRAP-1 peptide, and for the Ala-scan analogs,
the expected hydrophobic interaction mechanism for the
peptide–nonpolar ligand interaction was observed, with
decreases in ln k values as the  value was increased.
The relative trend for the binding of the TRAP-1 analogs
was in agreement with the effect anticipated for amino
acid substitution, i.e., the substitution of a more hydro-
phobic residue by a less hydrophobic residue in TRAP-2,
TRAP-3, and TRAP-4 leads to smaller k values, whereas
the replacement of a charged or polar residue in TRAP-5
and TRAP-6 by the alanine residue results in an increase
in the k value as compared to the naturally occurring
TRAP-1 (cf. Table 1).
The results from the molecular modeling and associated
energy minimization studies indicated that all TRAP ana-
logs have globular shape, assuming that a local minimum
not an absolute minimum was found. These investigations
show that TRAP-1 has a hydrophobic face consisting of
Phe2, Leu3, and Pro7. In Fig. 3 A is shown an overlay
presentation of five randomly selected energy-minimized
conformational structures for TRAP-1, having energy min-
ima between 63.1 and 73.8 kcal/mol. As evident from Fig.
3 A, the N-termini can be overlayed very well, with the Phe2
side chain of the peptide with the lowest energy minimum
closest to the core, whereas the C-termini with the Pro7 are
more flexible. In Fig. 3 B is shown the overlay presentation
for energy-minimized conformational structures for
TRAP-1, TRAP3, TRAP-4, and TRAP 5, where the Phe2
and Pro7 side chains are in close proximity. Although the
FIGURE 2 Plots of the logarithmic capacity factor, ln k, versus the
volume fraction of organic solvent, , for the alanine-scan TRAP peptides,
TRAP-2–6 at 298 K.
FIGURE 3 (A) Overlay presentation for five simulated energy-mini-
mized conformer structures for TRAP-1. (B) Overlay presentation of
TRAP and TRAP-related analogs TRAP-3, TRAP-4, and TRAP-5 with
Phe2 and Pro7 side chains in close proximity. (C) Overlay presentation of
TRAP-2 and TRAP-6 with the side chain of Pro7 distal to the side chain of
Phe2.
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N-termini and the residues at position 1, 2, and 4 are in good
alignment for these peptides, the location of the C-termini
varies according to the position of the Ala substitution. The
corresponding overlay presentation for the simulated ener-
gy-minimized conformational structures for TRAP-2 and
TRAP-6, where the Pro7 side chain is distal to the Phe2 side
chain, is shown in Fig. 3 C. Here, the Ala substitution of the
Phe residue has virtually no impact on the rest of the
molecule. However, as will be discussed later, the thermo-
dynamic data for both peptides revel that they behave dif-
ferently in response to increasing temperature.
The strength of binding of TRAP-1 and the Ala-scan
analogs to the immobilized n-octyl ligands, expressed in
terms of the relative Kassoc or ln k values, is largely in
agreement with the relative hydrophobicity values calcu-
lated for these peptides according to the procedures of
Wilce et al. (Wilce et al., 1995) (cf. Table 1). TRAP-3
and TRAP-4 have identical amino acid compositions but
different amino acid sequences with respect to positions
3 and 4 and nominally have the same relative hydropho-
bicity. However, as apparent from the ln k versus  plots
(Fig. 1 and 2) these peptides differ in terms of their
equilibrium binding constants with the immobilised n-
octyl ligands. The reason for this difference becomes
apparent when their possible structures, derived by mo-
lecular modeling methods, are examined. According to
the molecular modeling results, TRAP-4 is the far more
compact molecule, with Pro2, Leu3 and Phe2 collectively
generating a hydrophobic patch, only part of which can
be accessed by the immobilized n-octyl ligands. In con-
trast, TRAP-3 has the more open structure with Leu4 and
Pro7 in distal positions with the hydrophobic patch asso-
ciated with the Phe2 residue also more accessible to the
immobilized n-octyl ligands. This structure–interaction
correlation is in agreement with the observed changes in
heat capacity of these peptides (as discussed later).
van’t Hoff measurements
The van’t Hoff plots for TRAP-1 determined at different
-values with water-acetonitrile mixtures containing 0.09%
TFA are shown in Fig. 4. In all cases, for an individual
TRAP peptide examined in different solvent compositions
or with different TRAP peptides using the same solvent
composition, the correlation coefficients for the second-
order fit of the experimental data to the dependency of ln k
on 1/T were significantly higher than for a first-order fit (cf.
Tables 2 and 3) at both the 95% and 99% confidence
intervals. Thus, the van’t Hoff data for TRAP-1 in different
solvent compositions followed a quadratic relationship as
given by Eq. 3, e.g., when   0.17, the correlation coef-
ficient was r2  0.9995 at a 95% confidence level, with
significantly lower correlation coefficients determined
when the ln k versus 1/T data for TRAP-1 was fitted to a
first-order approximation for a defined -value over the
same temperature ranges. Consequently, the van’t Hoff de-
pendencies of TRAP-1 can be described in terms of hetero-
thermic processes (Boysen et al., 1999; Hearn and Zhao,
1999; Hearn 2001a) with Hassoc
0 , Sassoc
0 and Cp
0 all
dependent on T. As evident from Fig. 5, analogous nonlin-
ear van’t Hoff behavior was also evident in all cases for the
Ala-scan TRAP analogs at a defined value of , for example
at   0.14.
Changes in the entropy and enthalpy of
association for the TRAP-peptide–nonpolar
ligand interaction
The respective values of Hassoc
0 and Sassoc
0 for TRAP and
the Ala-scan analogs as a function of T and  were calcu-
lated according to Eqs. 3–5 and the results are shown in Fig.
6, 7, and Table 4. Thus, at 318 K and   0.17, the values
of Hassoc
0 and Sassoc
0 for TRAP-1 were 13.31 	 0.03 kJ
mol1 and 32.86 	 0.10 Jmol1K1, respectively, with
the results obtained for TRAP-1 (and the other peptides)
FIGURE 4 Plots of the logarithmic capacity factor, ln k, versus 1/T for
TRAP-1 at different  values with the experimental data fitted to a
second-order polynomial function (solid lines) with the 95% confidence
intervals depicted as dotted lines. The correlation coefficients for these
second-order fit and the corresponding first-order fit of the experimental
ln k versus 1/T data are listed in Table 2.
TABLE 2 The correlation coefficients for a linear and
quadratic fit of the corresponding experimental data to the
dependency of ln k versus 1/T for TRAP-1 at different
 values as shown in Figure 4
-Value
Correlation Coefficient, r2
Linear Fit Quadratic Fit
0.19 0.9760 0.9987
0.18 0.9774 0.9991
0.17 0.9842 0.9995
0.16 0.9829 0.9992
0.15 0.9918 0.9991
For all five plots, the second-order fit resulted in higher correlation coef-
ficients at both the 95 and 99% confidence interval than the first-order fit,
with differences ranging from 0.0073 to 0.0227.
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under the different temperature and solvent conditions sim-
ilarly exhibiting narrow confidence intervals. As evident
from Figs. 6 A and 7 A, the TRAP-1 peptide–ligand inter-
action was enthalpically-driven over the temperature range
of 278–358 K, with Hassoc
0 progressively becoming more
negative as T was increased. Moreover, the Hassoc
0 values
for the interaction of the TRAP peptides with the immobi-
lized n-octyl ligands were more negative for solvent mix-
tures of higher water content (Fig. 6 A). The heat required
for (partial) dehydration of the TRAP peptides prior to or
during adsorption to the immobilized n-octyl ligands differs
for the different peptides (Fig. 7 A), i.e., the heat required
under low temperature conditions (278 K) to dehydrate the
most hydrophilic peptide (TRAP-2) was 10–15 kJmol1
higher than that required to dehydrate the other more hy-
drophobic TRAP peptides. Both Hassoc
0 and Sassoc
0 were
temperature dependent with the TRAP peptides exhibiting
characteristic compensation temperatures given by TH
(where Hassoc
0  0) and TS (where Sassoc
0  0). When the
Hassoc
0 values for the TRAP peptides obtained from these
van’t Hoff plots are compared to related studies (Lin et al.,
2001), based on isothermal titration microcalorimetric pro-
cedures, for the determination of the adsorption enthalpy of
peptides and proteins when bound to immobilized n-alkyl
ligands, similar dependencies of Hassoc
0 , and hence Cp
0, on
T are evident at comparable solute concentrations. Com-
pared to large polypeptides or small proteins where Hassoc
0
differences of between 100 and 200 kJmol1 have been
observed under similar adsorption conditions over the
same temperature range of 278–338 K, the changes in
Hassoc
0 values for a specific TRAP peptide were rela-
tively small, i.e., Hassoc
0  15–30 kJmol1 over this
temperature range, values that are consistent with the
small molecular size, composition and solvational poten-
tial of these peptides.
As evident from Fig. 8, the interaction of TRAP-1 with
the n-octyl ligands involves an entropy–enthalpy compen-
sation phenomenon at different solvent compositions. En-
tropy-enthalpy compensation was also observed for the
TRAP Ala-scan analogs. Such behavior is consistent with
these peptide–ligand systems involving participation of
TABLE 3 The correlation coefficients and 95% confidence intervals for a linear and quadratic fit of the experimental ln k
versus 1/T data for TRAP-1 and its Alanine-scan peptide analogs at   0.14 corresponding to the data shown in Fig. 5
First Order Fit of the ln k versus 1/T  1000 (K1) Data
TRAP
Peptide
Variables 95% Confidence Intervals
r2Slope Y-Intercept X-Intercept Slope Y-Intercept
6 2.011 	 0.1428 3.449 	 0.4659 1.715 1.697 to 2.325 4.474 to 2.423 0.9475
5 1.526 	 0.140 2.339 	 0.457 1.533 1.218 to 1.834 3.344 to 1.334 0.9153
1 2.027 	 0.146 4.307 	 0.477 2.124 1.706 to 2.349 5.356 to 3.258 0.9460
3 1.916 	 0.111 5.079 	 0.361 2.651 1.672 to 2.159 5.874 to 4.284 0.9646
4 1.641 	 0.144 4.493 	 0.469 2.739 1.325 to 1.957 5.524 to 3.462 0.9223
2 1.027 	 0.176 2.893 	 0.574 2.818 0.6392 to 1.414 4.157 to 1.629 0.7556
Second Order Fit of the ln k versus 1/T  1000 (K1) Data
TRAP
Peptide
Variables 95% Confidence Intervals
r2A B C A B C
6 30.95 18.89 2.579 36.49 to 25.42 15.49 to 22.28 3.098 to 2.061 0.9960
5 28.61 17.65 2.464 35.50 to 21.72 13.42 to 21.87 3.109 to 1.819 0.9897
1 32.05 19.05 2.602 38.60 to 25.50 15.04 to 23.06 3.215 to 1.989 0.9946
3 24.37 13.75 1.809 32.08 to 16.66 9.027 to 18.48 2.531 to 1.087 0.9914
4 29.61 17.05 2.356 39.49 to 19.73 11.00 to 23.11 3.281 to 1.430 0.9816
2 35.19 20.84 3.029 45.18 to 25.20 14.72 to 26.97 3.964 to 2.093 0.9606
The resulting plots of the enthalpy of interaction, Hassoc
0 , entropy of interaction, Sassoc
0 , heat capacity, Cp
0, and Gibbs free energy of interaction, Gassoc
0 ,
versus T, derived from these first- and second-order regression analyses for TRAP-1 and its analogs are depicted in Figs. 6 and 7, respectively.
FIGURE 5 Plots of the logarithmic capacity factor, ln k, versus 1/T for
TRAP-1 and its alanine-scan peptide analogs at   0.14 with the exper-
imental data fitted to a second-order polynomial function (solid lines) with
the 95% confidence intervals depicted as dotted lines. The correlation
coefficients for these second-order fit and the corresponding first-order fit
of the experimental ln k versus 1/T data are listed in Table 3.
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FIGURE 6 Plots of (A) the change in enthalpy
Hassoc
0 versus T; (B) the change in entropy Sassoc
0
versus T; (C) the change heat capacity Cp
0 versus T;
and (D) the change in Gibbs free energy Gassoc
0 versus
T for the TRAP-1 peptide at different  values.
FIGURE 7 Plots of (A) the change in enthalpy
Hassoc
0 versus T; (B) the change in entropy Sassoc
0
versus T; (C) the change heat capacity Cp
0 versus T;
and (D) the change in Gibbs free energy Gassoc
0 versus
T for the TRAP-1 and its Alanine-scan peptide analogs
at   0.14.
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multiple, weak, intermolecular forces (Dunitz, 1995). The
results indicate that the binding of TRAP 1–6 peptides
within this interactive molecular system (including solvent)
was generally exothermic (i.e., involved a negative Hassoc
0
under most conditions) but was compensated by a decrease
in Sassoc
0 that results from the reduced molecular flexibility
of the peptide on binding to the immobilized n-octyl li-
gands. As the temperature was increased, the TRAP-related
peptides and the n-octyl ligands are progressively solvated
to a greater extent, resulting in smaller contact areas, and
thus reduced association between the peptides with the
nonpolar environment of the n-octyl ligands.
TABLE 4 The slopes and 95% confidence intervals of the dependence of the enthalpy of interaction, Hassoc
0 , entropy of
interaction, Sassoc
0 , heat capacity, Cp
0, and Gibbs free energy of interaction, Gassoc
0 , on temperature for TRAP-1 and its alanine
scan peptide analogs at   0.14, based on a first- and second-order fit of the experimental ln k versus 1/T data shown in Fig. 5
A Enthalpy, Hassoc
0 (kJmol1) versus Temperature, T (K)
TRAP
First-Order Fit of the ln k versus 1/T  1000
(K1) Data*
Second-Order Fit of the ln k versus 1/T  1000
(K1) Data†
Slope‡
95% Confidence
Interval of Slope
Slope
 102
95% Confidence
Interval of Slope  102
6 0 n.d.§ 45.55 	 0.74 43.91 to 47.18
5 0 n.d. 43.57 	 0.71 42.01 to 45.13
1 0 n.d. 45.90 	 0.75 44.26 to 47.55
3 0 n.d. 31.89 	 0.52 30.75 to 33.04
4 0 n.d. 41.52 	 0.68 40.03 to 43.01
2 0 n.d. 53.38 	 0.87 51.47 to 55.30
B Entropy, Sassoc
0 (Jmol1K1) versus Temperature, T (K)
Slope
95% Confidence
Interval of Slope Slope
95% Confidence
Interval of Slope
6 0 n.d. 1.49 	 0.04 1.41 to 1.57
5 0 n.d. 1.42 	 0.03 1.35 to 1.50
1 0 n.d. 1.50 	 0.04 1.42 to 1.58
3 0 n.d. 1.04 	 0.03 0.99 to 1.10
4 0 n.d. 1.36 	 0.03 1.28 to 1.43
2 0 n.d. 1.75 	 0.04 1.65 to 1.84
C Heat capacity, Cp
0 (kJmol1K1) versus Temperature, T (K)
Slope
 104
95% Confidence
Interval of Slope  104
Slope
 103
95% Confidence
Interval of Slope  103
6 1.78 	 0.04 1.69 to 1.87 2.98 	 0.07 2.82 to 3.14
5 1.34 	 0.05 1.22 to 1.46 2.85 	 0.07 2.70 to 3.00
1 1.88 	 0.05 1.78 to 1.98 3.02 	 0.07 2.84 to 3.16
3 1.62 	 0.04 1.52 to 1.71 2.08 	 0.05 1.97 to 2.20
4 1.44 	 0.04 1.34 to 1.54 2.72 	 0.07 2.57 to 2.87
2 0.95 	 0.05 0.84 to 1.05 3.49 	 0.09 3.31 to 3.68
D Gibbs free energy, Gassoc
0 (kJmol1) versus Temperature, T (K)
Slope
 103
95% Confidence
Interval of Slope  103
Slope
 103
95% Confidence
Interval of Slope  103
6 28.67 	 4.45 19.76 to 37.58 29.77 	 3.71 21.61 to 37.94
5 19.44 	 4.19 11.06 to 27.89 20.50 	 3.55 12.67 to 28.32
1 35.80 	 2.28 31.24 to 40.66 36.91 	 3.74 28.68 to 45.15
3 42.22 	 4.45 34.36 to 52.32 42.99 	 2.60 37.27 to 48.71
4 37.35 	 4.64 28.05 to 46.75 38.36 	 3.39 30.91 to 45.81
2 24.07 	 4.53 14.90 to 33.23 25.37 	 4.35 15.79 to 34.94
In the case of a linear dependence of ln k on 1/T, Hassoc
0 and Sassoc
0 are expected to be independent of T, and thus, theoretically, the slopes of the plots
of Hassoc
0 versus T and Sassoc
0 versus T should be zero as observed from the data analysis using the GraphPad Prism version 2.01 software package
(Graphpad, San Diego, CA) for statistical analysis.
*Data fitted according to ln k  b(0)  b(1)/T  ln .
†Data fitted according to ln k  b(0)  b(1)/T  b(2)/T
2  ln .
‡The Prism software package reported this as a horizontal line of slope equal to zero.
§n.d., Not calculated by the statistical analysis package.
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Changes in the heat capacity of association for
the TRAP peptide–nonpolar ligand interaction
Another thermodynamic parameter important for character-
izing the TRAP–n-octyl ligand interaction is the change in
heat capacity, Cp
0, with an increase in the extent of burial
of hydrophobic surfaces in a nonpolar environment yielding
a more negative value of Cp
0 (Ross and Rekharsky, 1996).
It is widely accepted that Cp
0 is proportional to the acces-
sible surface area of a peptide or protein, which can be
partitioned into an apolar surface (with the energetics re-
lated to the hydrophobic effect) or into a polar surface
(where the energetics are predominantly related to hydro-
gen-bonding effects) (Murphy and Gill, 1991; Murphy,
1999). To assess the nature of the dependence of Cp
0 on
temperature for these TRAP peptides, the experimental data
used for the generation of the ln k versus 1/T plots for
TRAP-1 at different solvent compositions and for TRAP-
1–Trap-6 at   0.14 were fitted to the relevant equations
with and without Cp
0 having a temperature dependence,
i.e., ln k fitted as a first-order or second-order dependence
on 1/T. These results are found in Table 3–6.
Figure 6 C shows that the change in Cp
0 for TRAP-1–
n-octyl ligand interaction was negative under all solvent
conditions as expected for a hydrophobic interaction pro-
cess. Thus, at 318 K and   0.17, the value of Cp
0 for
TRAP-1 was 0.192 	 0.002 kJmol1K1. Moreover, the
corresponding Cp
0 values for TRAP-1 obtained under the
other temperature and solvent conditions or the related
analogs obtained at   0.14 similarly exhibiting negative
values with small standard deviations at the 95% and 99%
confidence intervals for second-order fit of the experimental
data (Table 4 and 6) for the ln k dependency on 1/T
according to Eq. 3. In all cases, the Cp
0 values followed the
important criterion of being 
0 and 0 under the experi-
mental conditions investigated with the Cp
0 values (Figs.
6 C and 7 C) becoming more positive at higher tempera-
tures, indicating a decrease in the hydrophobic contact area
associated with the peptide–nonpolar ligand interaction.
This behavior was also paralleled by changes in the Gibbs
free energy, Gassoc
0 , as the temperature was increased
(Figs. 6 D and 7 D). Thus, the plots of Gassoc
0 versus T for
these TRAP-related peptides confirm that their interaction
with the n-octyl ligands was spontaneous at all tempera-
tures, but their interactions became less favorable at more
elevated temperatures. These findings indicate a small but
nevertheless significant dependence of Cp
0 values (e.g.,
0.13 kJmol1K1 	 0.01  Cp
0  0.27
kJmol1K1 	 0.01) on the temperature over the range of
FIGURE 8 Plot of the change in entropy Sassoc
0 versus the change in
enthalpy Hassoc
0 for the TRAP-1 peptide at different  values.
TABLE 5 The correlation coefficients and 95% confidence intervals for a linear and quadratic fit of the experimental ln k
versus 1/T data for TRAP-1 at different  values, corresponding to the data shown in Fig. 4
First Order Fit of the ln k versus 1/T  1000 (K1) Data
TRAP-1
 Value
Variables 95% Confidence Intervals
r2Slope Y-Intercept X-Intercept Slope Y-Intercept
0.19 1.410 	 0.067 3.968 	 0.219 2.813 1.263 to 1.558 4.449 to 3.486 0.9757
0.18 1.416 	 0.065 3.685 	 0.212 2.602 1.274 to 1.559 4.151 to 3.220 0.9775
0.17 1.546 	 0.059 3.817 	 0.193 2.469 1.416 to 1.676 4.242 to 3.392 0.9841
0.16 1.629 	 0.065 3.754 	 0.212 2.305 1.486 to 1.772 4.221 to 3.287 0.9828
0.15 1.925 	 0.053 4.327 	 0.172 2.248 1.809 to 2.041 4.706 to 3.948 0.9918
Second Order Fit of the ln k versus 1/T  1000 (K1) Data
TRAP-1
 Value
Variables 95% Confidence Intervals
r2A B C A B C
0.19 17.05 9.435 1.226 19.23 to 14.86 8.095 to 10.78 1.431 to 1.022 0.9987
0.18 16.42 9.232 1.195 18.22 to 14.63 8.131 to 10.33 1.363 to 1.026 0.9991
0.17 15.48 8.705 1.094 16.96 to 14.01 7.804 to 9.607 1.232 to 0.9565 0.9995
0.16 16.45 9.419 1.191 18.48 to 14.42 8.177 to 10.66 1.380 to 1.001 0.9992
0.15 14.28 8.035 0.9339 16.79 to 11.78 6.501 to 9.569 1.168 to 0.6995 0.9991
The resulting plots of the enthalpy of interaction, Hassoc
0 , entropy of interaction, Sassoc
0 , heat capacity, Cp
0, and Gibbs free energy of interaction, Gassoc
0 ,
versus T, derived from these first- and second-order regression analyses for TRAP-1 and its analogs are depicted in Fig. 6 and 7, respectively.
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278–338 K for TRAP-1 and its Ala-scan analogs and are
consistent with the small molecular size and lack of well-
developed secondary structure of these peptides under these
experimental conditions. These Cp
0 values are comparable
in value to Cp
0 for the highly stabilized equine cytochrome
c (Cp
0  0.9 kJmol1K1) (R. I. Boysen, A. J. O. Jong
and M. T. W. Hearn, in preparation) but are significantly
smaller than found for the interaction of multimeric coiled-
coil polypeptides, such as the transcription factors c-Jun or
c-Fos, with nonpolar ligands, i.e., Cp
0  43.8
kJmol1K1 for the interactions of this coiled-coil polypep-
tide with n-octyl ligands under similar experimental condi-
tions (Boysen et al., 2002). In this latter case with the homo-
or hetero- c-Jun or c-Fos dimers, the experimental findings
have documented that a two-state unfolding process occurs
with the coiled coil c-Jun/c-Fos polypeptide dimers first
uncoiling and the individual -helical coils then transition-
ing toward random coil structures with large incremental
changes in Cp
0 arising as the temperature was increased.
Beside the overall trends in the Cp
0 values of the TRAP
TABLE 6 The slopes and 95% confidence intervals of the dependence of the enthalpy of interaction, Hassoc
0 , entropy of
interaction, Sassoc
0 , heat capacity, Cp
0, and Gibbs free energy of interaction, Gassoc
0 , on temperature for TRAP-1 peptide at
different  values, based on a first- and second-order fit of the experimental ln k versus 1/T data shown in Fig. 6
A Enthalpy, Hassoc
0 (kJmol1) versus Temperature, T (K)
 Value
First-Order Fit of the ln k versus 1/T  1000
(K1) Data*
Second-Order Fit of the ln k versus 1/T  1000
(K1) Data†
Slope‡
95% Confidence
Interval of Slope
Slope
 102
95% Confidence
Interval of Slope  102
0.19 0 n.d.§ 21.54 	 0.35 22.31 to 20.77
0.18 0 n.d. 21.12 	 0.35 21.87 to 20.36
0.17 0 n.d. 19.31 	 0.32 20.00 to 18.62
0.16 0 n.d. 20.98 	 0.34 21.73 to 20.23
0.15 0 n.d. 16.52 	 0.27 17.11 to 0.16
B Entropy, Sassoc
0 (Jmol1K1) versus Temperature, T (K)
Slope
95% Confidence
Interval of Slope Slope
95% Confidence
Interval of Slope
0.19 0 n.d. 0.70 	 0.02 0.74 to 0.67
0.18 0 n.d. 0.69 	 0.02 0.73 to 0.65
0.17 0 n.d. 0.63 	 0.02 0.67 to 0.60
0.16 0 n.d. 0.69 	 0.02 0.72 to 0.65
0.15 0 n.d. 0.54 	 0.01 0.57 to 0.51
C Heat capacity, Cp
0 (kJmol1K1) versus Temperature, T (K)
Slope
 104
95% Confidence
Interval of Slope  104
Slope
 103
95% Confidence
Interval of Slope  103
0.19 1.21 	 0.049 1.10 to 1.32 1.40 	 0.04 1.36 to 1.48
0.18 1.28 	 0.048 1.17 to 1.38 1.38 	 0.03 1.31 to 1.45
0.17 1.33 	 0.050 1.22 to 1.44 1.26 	 0.03 1.20 to 1.32
0.16 1.44 	 0.053 1.32 to 1.56 1.37 	 0.03 1.29 to 1.44
0.15 1.80 	 0.044 1.70 to 1.90 1.08 	 0.02 1.02 to 1.13
D Gibbs free energy, Gassoc
0 (kJmol1) versus Temperature, T (K)
Slope
 103
95% Confidence
Interval of Slope  103
Slope
 103
95% Confidence
Interval of Slope  103
0.19 32.98 	 0.00 n.d. 33.52 	 1.75 29.66 to 37.38
0.18 30.63 	 0.00 n.d. 31.15 	 1.72 27.36 to 34.93
0.17 31.75 	 0.00 n.d. 32.22 	 1.57 28.75 to 35.68
0.16 31.22 	 0.00 n.d. 31.74 	 1.71 27.97 to 35.51
0.15 35.97 	 0.00 n.d. 36.37 	 1.35 33.41 to 39.33
In the case of a linear dependence of ln k on 1/T, Hassoc
0 and Sassoc
0 are expected to be independent of T, and thus, theoretically, the slopes of the plots
of Hassoc
0 versus T and Sassoc
0 versus T should be zero as observed from the data analysis using the GraphPad Prism version 2.01 software package
(Graphpad, San Diego, CA) for statistical analysis.
*Data fitted according to ln k  b(0)  b(1)/T  ln .
†Data fitted according to ln k  b(0)  b(1)/T  b(2)/T
2  ln .
‡The Prism software package reported this as a horizontal line of slope equal to zero.
§n.d., Not calculated by the statistical analysis package.
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analogs as depicted in Fig. 7 C with respect to temperature,
the incremental changes in Cp
0 with regard to temperature
or residue number, namely Cp,T
0 and Cp,Nres
0 , over the
temperature range of 278–338 K are highly diagnostic.
Thus, the larger the Cp,T
0 value, the more sensitive is the
peptide to heat, which translates into less structural rigidity
of the peptide as it interacts with the nonpolar ligand. The
observed variations in the Cp
0 and Cp
0 values follow the
order expected for the reduction in hydrophobic stabiliza-
tion of the various TRAP peptides as their structures are
kinetically destabilized at higher temperatures. Thus, in a
solvent composition whereby   0.14, the Cp,T
0 value
for the more open TRAP-3 was the lowest at 2.1 Jmol1K2
with the more compact TRAP-4 exhibiting a Cp,T
0 value
of 2.7 Jmol1K2, whereas, for the most compact structure,
TRAP-2, the Cp,T
0 value was 3.5 Jmol1K2. It is well
known that polypeptide or protein denaturation or the trans-
fer of nonpolar compounds to more aqueous environments
is accompanied by a heat capacity increase and associated
enthalpy change (Makhatadze and Privalov, 1990; Graziano
et al., 1998). Changes in the partial molar heat capacity of
small peptides, such as Gly-Xaa-Gly, in aqueous solutions
over a temperature range of 353 K, as determined by dif-
ferential scanning microcalorimetry, have been reported to
be 0.2–0.3 kJmol1K1 (Hackel et al., 1998, 1999) with
corresponding changes in the enthalpy of 10 to 20
kJmol1. As apparent from Figs. 6 and 7, variations in the
Cp
0 or Hassoc
0 values for all of the TRAP peptides in
association with the n-octyl ligands have similar magnitudes
as the temperature was increased.
In Fig. 9 C are shown the plots of Cp
0 versus Atotal for
the TRAP-related peptides in their folded (globular) con-
formations (Table 2) over a defined temperature range of
273–338 K and   0.14, where the trend was apparent for
larger Cp
0 values to follow an increase in the molecular
surface-area properties of these peptides. These data reveal
two notable effects. First, for TRAP-2, which has the high-
est Cp
0 value, it can be concluded that this is the most
heat-sensitive TRAP peptide, although TRAP-2 is not the
most compact analog, as assessed from the molecular mod-
eling and energy minimization data (see Fig. 3 C). A pos-
sible explanation for the larger Cp
0 value of TRAP-2 is
that the stabilizing effect of the –n interaction of the Phe2
with Pro7 is missing. The change in the thermodynamic
properties of TRAP-2 with the Phe2 replaced by Ala mirrors
the effect of elimination of the -phenyl side-chain group in
biological assays, which is associated with the complete loss
of receptor activation (Nose et al., 1998a), i.e., TRAP-2 acts
as an antagonist.
The other effect evident from the experimental data re-
lated to the change in heat capacity versus the molecular
surface area is associated with TRAP-3. This TRAP analog
was the least heat sensitive of the TRAP-related peptides
with the data consistent with the conclusion that TRAP-3 is
the least compact peptide. When compared with TRAP-4,
which has identical amino acid composition but different
FIGURE 9 Plot of the (A) change in enthalpy
Hassoc
0 versus Atotal; (B) change in entropy Sassoc
0
versus Atotal; (C) change in heat capacity Cp
0 versus
Atotal; and (D) change in Gibbs free energy Gassoc
0
versus Atotal for the TRAP-1 and its Alanine-scan
peptide analogs at   0.14.
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sequence with respect to position 4, the results are in good
agreement with the findings from the molecular modeling
studies, whereby TRAP-3 has a more open structure with
Leu4 and Pro7 in a distal position (see Fig. 3 B). Analogous
behavior was evident for TRAP-3 in the corresponding plots
of Hassoc
0 , Sassoc
0 , and Gassoc
0 versus Atotal, (Fig. 9, A, B,
and D).
Several conclusions can be drawn from these results.
First, the capacity factor data for the alanine scan TRAP
peptide are in good agreement with solvophobic theory
(Haidacher et al., 1996; Hearn and Zhao, 1999) for peptides
with identical compositions but with different amino-acid
sequences. Thus, the thermodynamic discrimination of
these TRAP-related peptides is associated with a compen-
sation phenomenon involving rearrangement of water mol-
ecules. The observation that TRAP-2 has the highest Cp
0
value for the binding to immobilized n-octyl ligands and
thermodynamically is located in a different region of the
enthalpy–entropy compensation plot from the other TRAP-
related peptides with agonist function is indicative of a
different solvent displacement process on interaction with
the immobilized nonpolar ligands. This conclusion is also
consistent with previous studies with G-protein-coupled re-
ceptors and ligand-gated ion channel receptors, indicating
that solvent effects might similarly be responsible for the in
vitro thermodynamic discrimination of agonists and antag-
onists. According to currently accepted general models for
such association processes involving agonist interaction
with -adrenergic (Weiland et al., 1979) and A1 adenosine
(Borea et al., 1992) receptors, the entropy-driven docking of
agonists to the relevant receptor involves displacement of
water molecules from a binding site pocket, which previ-
ously was filled with a network of structured water mole-
cules. This displacement of structured water from the “re-
ceptor” binding site accounts for the observed larger
increase in entropy for agonists. A parallel situation appears
to occur for the binding of the TRAP-related peptides to the
immobilized n-octyl ligands, i.e., the differences noted in
the interaction thermodynamics of the various TRAP pep-
tide analogs with the nonpolar ligands are qualitatively
associated with solvational/desolvational transitions involv-
ing equilibrium between closely packed and more open
forms of water (Klotz, 1999). Because the magnitude of this
phenomenon will be dependent on the molecular character-
istics of the peptide, determination of the change in heat
capacity Cp
0 represents a valuable diagnostic parameter,
allowing comparative assessment of peptide analogs in re-
spect of their ligand-binding behavior. Second, the derived
thermodynamic data are in full agreement with the biophys-
ical and molecular properties of the peptides, allowing the
peptide–ligand interaction to be structurally rationalized in
conjunction with other experimental procedures, e.g., mo-
lecular modeling methods. Third, the above results indicate
that synthetic TRAP analogs can be designed to maximize
their Cp
0 values on binding to immobilized nonpolar
ligands or the corresponding in vitro receptor systems based
on their position in the corresponding entropy–enthalpy
plots. Analogs involving intramolecular hydrophobic –
interaction, in which the stabilizing effect of the interaction
between the side chains of Phe2 and Pro7 is mimicked,
potentially represent one such group of agonist candidates.
The combinatorial synthesis and selection of such analogs
are currently underway, and their evaluation will be re-
ported subsequently.
These investigations were supported by the Australian Research Council.
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